ENTA
NASDAQ · Biotechnology
Enanta Pharmaceuticals Inc
$11.95
-0.47 (-3.78%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+272.8% upside
Low Target
$33.16
Average Target
$44.55
High Target
$53.28
Current Price
$11.95
Current
$11.95
$11.95
Target
$44.55
$44.55
$33.16
$44.55 avg
$53.28
Scenario Analysis
Bear Case
$33.16
177.5%
Low target
Base Case
$44.55
+272.8%
Avg target
Bull Case
$53.28
+345.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$17.15
-30.3% from high
52-Week Low
$7.05
+69.5% from low
Target vs 52W High
$44.55
+159.8% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.8% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +139.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -15.1% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -17.9% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.2% |